Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: CMP008
MIFTS: 52

Compartment Syndrome

Categories: Cardiovascular diseases, Rare diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Compartment Syndrome

About this section

MalaCards integrated aliases for Compartment Syndrome:

Name: Compartment Syndrome 12 77 54 15
Compartment Syndromes 56 45 74
Compartmental Syndrome 12

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Cardiovascular diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:682
ICD9CM 36 958.90
MeSH 45 D003161
NCIt 51 C118422
SNOMED-CT 69 45781009
ICD10 34 T79.A0
UMLS 74 C0009492
Sources

Summaries for Compartment Syndrome

About this section
MalaCards based summary : Compartment Syndrome, also known as compartment syndromes, is related to anterior compartment syndrome and burns, and has symptoms including muscle weakness, myalgia and muscle cramp. An important gene associated with Compartment Syndrome is MB (Myoglobin), and among its related pathways/superpathways are Formation of Fibrin Clot (Clotting Cascade) and Complement and coagulation cascades. The drugs Clopidogrel and Warfarin have been mentioned in the context of this disorder. Affiliated tissues include kidney, liver and heart, and related phenotypes are growth/size/body region and homeostasis/metabolism

Wikipedia : 77 Compartment syndrome is a condition in which increased pressure within one of the body''s anatomical... more...

Sources

Related Diseases for Compartment Syndrome

About this section

Diseases in the Compartment Syndrome family:

Anterior Compartment Syndrome

Diseases related to Compartment Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 329)
# Related Disease Score Top Affiliating Genes
1 anterior compartment syndrome 34.4 F2 PIK3C2A
2 burns 30.7 ALB TNF
3 gas gangrene 30.6 MB PIK3C2A
4 myositis 30.5 CHKB MB PIK3C2A
5 factor viii deficiency 30.4 F2 F8
6 thrombosis 30.3 F2 F7 F8
7 acute myocardial infarction 30.2 CHKB MB PIK3C2A
8 plexopathy 30.1 MB PIK3C2A
9 hemophilia 30.1 F2 F7 F8
10 hemophilia a 30.0 F7 F8
11 acute liver failure 30.0 ALB F2 SLC17A5
12 disseminated intravascular coagulation 29.9 F2 F7 MB PIK3C2A
13 respiratory failure 29.9 ALB PIK3C2A TNF
14 dengue hemorrhagic fever 29.8 ALB F2 TNF
15 infantile liver failure syndrome 1 29.8 ALB F2 SLC17A5
16 neuroleptic malignant syndrome 29.8 CHKB MB PIK3C2A
17 hepatorenal syndrome 29.8 ALB F2
18 anuria 29.8 ALB MB PIK3C2A
19 eclampsia 29.6 ALB F2 TNF
20 liver disease 29.5 ALB F2 SLC17A5 TNF
21 endocarditis 29.4 ALB F2 PIK3C2A TNF
22 factor vii deficiency 29.4 F2 F7 F8
23 hemophilia b 29.4 F2 F7 F8
24 myocardial infarction 28.6 ALB CHKB F2 F7 F8 MB
25 heart disease 28.3 ALB EVC2 F2 F7 F8 PIK3C2A
26 popliteal cyst 11.3
27 pancreatitis 10.4
28 virus associated hemophagocytic syndrome 10.4 MB PIK3C2A
29 interstitial myocarditis 10.4 MB PIK3C2A
30 trichostrongyloidiasis 10.4 ALB PIK3C2A
31 posterior myocardial infarction 10.4 MB PIK3C2A
32 antipyrine metabolism 10.4 ALB F2
33 non-a-e hepatitis 10.4 ALB F2
34 myositis fibrosa 10.4 MB PIK3C2A
35 glycogen storage disease v 10.4 CHKB MB
36 acute pancreatitis 10.4
37 epstein-barr virus hepatitis 10.4 ALB F2
38 adult dermatomyositis 10.4 CHKB TNF
39 anteroseptal myocardial infarction 10.3 ALB PIK3C2A
40 subendocardial myocardial infarction 10.3 F2 MB
41 abdominal tuberculosis 10.3 ALB F2
42 cardiogenic shock 10.3 PIK3C2A TNF
43 hepatic tuberculosis 10.3 ALB F2
44 ischemia 10.3
45 hepatic coma 10.3 ALB F2
46 erysipelas 10.3 PIK3C2A TNF
47 fainting 10.3 CHKB F8
48 chronic graft versus host disease 10.3 ALB TNF
49 pericardium disease 10.3 ALB PIK3C2A
50 marburg hemorrhagic fever 10.3 F2 TNF

Graphical network of the top 20 diseases related to Compartment Syndrome:



Diseases related to Compartment Syndrome
Sources

Symptoms & Phenotypes for Compartment Syndrome

About this section

UMLS symptoms related to Compartment Syndrome:


muscle weakness, myalgia, muscle cramp, muscle rigidity, muscle spasticity

MGI Mouse Phenotypes related to Compartment Syndrome:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 9.76 EVC2 F2 F7 HELLS MB PIK3C2A
2 homeostasis/metabolism MP:0005376 9.65 ALB CHKB F2 F7 F8 HELLS
3 mortality/aging MP:0010768 9.32 ALB EVC2 F2 F7 F8 HELLS
Sources

Drugs & Therapeutics for Compartment Syndrome

About this section

Drugs for Compartment Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 189)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clopidogrel Approved Phase 4,Phase 3,Phase 2 120202-66-6, 113665-84-2 60606
2
Warfarin Approved Phase 4,Phase 3,Phase 2 81-81-2 54678486 6691
3
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-78-2 2244
4
Rivaroxaban Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 366789-02-8
5
Ticagrelor Approved Phase 4,Phase 3 274693-27-5 9871419
6
Ropivacaine Approved Phase 4 84057-95-4 175805 71273
7
Nefopam Approved, Investigational Phase 4 13669-70-0
8
Clonidine Approved Phase 4 4205-90-7 2803
9
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
10
Acetaminophen Approved Phase 4 103-90-2 1983
11
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
12
Phenprocoumon Approved, Investigational Phase 4 435-97-2 54680692 9908
13
Apixaban Approved Phase 4,Phase 3,Phase 2,Not Applicable 503612-47-3 10182969
14
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6 46507594 772
15
Dalteparin Approved Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6
16
Enoxaparin Approved Phase 4,Phase 3,Phase 2 9005-49-6 772
17 Menaquinone Approved, Investigational Phase 4,Phase 3,Phase 2 1182-68-9
18
Phylloquinone Approved, Investigational Phase 4,Phase 3,Phase 2 84-80-0
19
Lidocaine Approved, Vet_approved Phase 4,Not Applicable 137-58-6 3676
20
Nadroparin Approved, Investigational Phase 4
21
Tinzaparin Approved Phase 4,Phase 3,Phase 2 9041-08-1, 9005-49-6 25244225
22
Fondaparinux Approved, Investigational Phase 4,Phase 3,Phase 2 104993-28-4
23
Nitroglycerin Approved, Investigational Phase 4 55-63-0 4510
24
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
25
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
26
tannic acid Approved Phase 4,Not Applicable 1401-55-4
27
Benzocaine Approved, Investigational Phase 4,Not Applicable 1994-09-7, 94-09-7 2337
28
Edoxaban Approved Phase 4,Phase 3,Phase 2,Not Applicable 480449-70-5
29
Tirofiban Approved Phase 4 144494-65-5 60947
30
Serine Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 56-45-1 5951
31 Kava Approved, Investigational, Nutraceutical Phase 4 9000-38-8
32
Choline Approved, Nutraceutical Phase 4 62-49-7 305
33
Menadione Approved, Nutraceutical Phase 4,Phase 3,Phase 2 58-27-5 4055
34
Calcium Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2 7440-70-2 271
35
Dabigatran Investigational Phase 4,Phase 3,Phase 2,Not Applicable 211914-51-1
36 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Not Applicable
37 Purinergic P2Y Receptor Antagonists Phase 4,Phase 3,Phase 2
38 Purinergic P2 Receptor Antagonists Phase 4,Phase 3,Phase 2
39 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
40 Factor Xa Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
41 Antithrombin III Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
42 HIV Protease Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
43 Serine Proteinase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
44
protease inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
45 Platelet Aggregation Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
46 Antithrombins Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
47 Anticoagulants Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
48 Narcotics Phase 4,Not Applicable
49 Analgesics Phase 4,Phase 3,Phase 2,Not Applicable
50 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 215)
# Name Status NCT ID Phase Drugs
1 Hypertonic Saline Resuscitation in Trauma Patients After Hemorrhage Control Unknown status NCT02542241 Phase 4 Sodium Chloride [3%];Sodium Chloride [0.9%]
2 Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Unknown status NCT02334254 Phase 4 rivaroxaban and ticagrel therapy;triple antithrombotic regimen with warfarin, asipirin and clopidogrel
3 Epidural Analgesia for Pancreatitis (Epipan Study) Unknown status NCT02126332 Phase 4
4 Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban Unknown status NCT02549963 Phase 4 Rivaroxaban
5 The Study of Using Esophageal Pressure to Guide the PEEP Setting in Abdominal Hypertension Patients Who Undergoing Mechanical Ventilation Unknown status NCT01825304 Phase 4
6 Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF Unknown status NCT02256683 Phase 4 Dabigatran etexilate;Phenprocoumon
7 Colloids in Severe Trauma Completed NCT00890383 Phase 4 tetrastarch (Voluven)
8 Relation Between Intrabdominal Pressure and Collapsibility Index of Inferior Vena Cava Before and After Fluid Therapy Completed NCT01553422 Phase 4
9 Efficacy of DBM on Fractures of the Shinbone (Tibia) Completed NCT00299052 Phase 4
10 ABRA Abdominal Closure System in Open Abdomen Management Completed NCT00754156 Phase 4
11 Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Completed NCT03046693 Phase 4 Group A Citicoline 1000 mg oral tablet;Group B placebo oral tablet
12 AngioSeal Versus Radial Approach in Acute Coronary Syndrome Completed NCT01653587 Phase 4
13 Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT Completed NCT00585182 Phase 4 Enoxaparin 0.5 mg/kg once daily
14 Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT) Completed NCT02348723 Phase 4 Warfarin;Dabigatran Etexilate 150mg
15 Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery Completed NCT01884337 Phase 4 Apixaban
16 Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) Completed NCT02100228 Phase 4 Apixaban;Parenteral heparin and/or oral Vitamin K antagonist
17 The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis Completed NCT01507766 Phase 4 early enteral nutrition;Delayed enteral nutrition
18 Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation Recruiting NCT02426944 Phase 4 NOAC
19 Subcutaneous Nitroglycerin to Facilitate Trans-radial Access. Recruiting NCT03304496 Phase 4 Nitroglycerin 100 MCG/ML Injectable Solution;Saline Solution
20 Apixaban for Extended Anticoagulation (APIDULCIS) Recruiting NCT03678506 Phase 4 Apixaban
21 Calf Deep Vein Thrombosis Treatment Trial Recruiting NCT03590743 Phase 4 Apixaban
22 Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation Recruiting NCT01938248 Phase 4 Apixaban;aspirin
23 Effect of Sedation on Intra-abdominal Pressure Recruiting NCT02944292 Phase 4 Propofol
24 Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite Recruiting NCT02570347 Phase 4 Co-amoxiclav
25 Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy Recruiting NCT01828697 Phase 4 Low dose nadroparin;Intermediate dose nadroparin;Low dose enoxaparin;Intermediate dose enoxaparin;Low dose dalteparin;Intermediate dose dalteparin;Fixed low dose tinzaparin;Intermediate dose tinzaparin
26 Vascular Closure Device Versus Transradial Approach in Primary Percutaneous Coronary Intervention Active, not recruiting NCT02831166 Phase 4
27 Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia Active, not recruiting NCT01727401 Phase 4 Fondaparinux
28 ORthopaedic Trauma Anemia With Conservative Versus Liberal Transfusion Enrolling by invitation NCT02972593 Phase 4
29 Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease Not yet recruiting NCT03718559 Phase 4 Edoxaban;Single Antiplatelet Agents
30 Early Initiation of Low Dose Tirofiban for Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction Not yet recruiting NCT03797729 Phase 4 Tirofiban;Normal saline
31 Muscle Oxygenation and Skin Pigmentation Withdrawn NCT00747162 Phase 4
32 an Educational Program About Abdominal Compartment Syndrome Unknown status NCT02639013 Phase 3
33 The Influence of Fluid Removal Using Continuous Venovenous Hemofiltration (CVVH) on Intra-abdominal Pressure and Kidney Function Unknown status NCT01077895 Phase 3
34 Transradial Versus Transulnar Artery Approach for Coronary Interventions Unknown status NCT01364532 Phase 3
35 Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI) Unknown status NCT02817789 Phase 3 Ticagrelor alone;Combination lysine acetylsalicylate - clopidogrel
36 Percutaneous Catheter Decompression in the Treatment of Elevated Intra-abdominal Pressure Completed NCT01230255 Phase 3
37 RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial Completed NCT00808067 Phase 3 dabigatran dose 1;dabigatran dose 2
38 Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) Completed NCT02064439 Phase 3 BAY 59-7939;BAY 59-7939;ASA
39 Rivaroxaban for Patients With Antiphospholipid Syndrome Completed NCT02926170 Phase 3 Rivaroxaban;acenocumarol
40 A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants Completed NCT02555878 Phase 3 Rivaroxaban;Placebo
41 Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban Completed NCT02746185 Phase 3 rivaroxaban;Low-molecular-weight heparin
42 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery Completed NCT00452530 Phase 3 Enoxaparin;Apixaban;Enoxaparin-matching placebo;Apixaban-matching placebo
43 The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086) Completed NCT00765063 Phase 2, Phase 3 Fragmin
44 Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation Completed NCT00412984 Phase 3 warfarin;apixaban
45 Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038) Completed NCT01422304 Phase 3 Sugammadex;neostigmine and glycopyrrolate or atropine;Placebo to neostigmine;Placebo to sugammadex
46 Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism Completed NCT00633893 Phase 3 Apixaban;Placebo
47 Pilot Study for the SQUEEZE Trial Completed NCT01973907 Phase 3
48 Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis) Completed NCT00443053 Phase 3 Fondaparinux 2.5mg or placebo
49 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) Completed NCT00423319 Phase 3 Enoxaparin;Apixaban;Enoxaparin-matching placebo;Apixaban-matching placebo
50 Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients Completed NCT00662831 Phase 2, Phase 3 Fragmin/ Dalteparin Sodium;Placebo for Fragmin/ Dalteparin Sodium

Search NIH Clinical Center for Compartment Syndrome

Cochrane evidence based reviews: compartment syndromes

Sources

Genetic Tests for Compartment Syndrome

About this section
Sources

Anatomical Context for Compartment Syndrome

About this section

MalaCards organs/tissues related to Compartment Syndrome:

42
Kidney, Liver, Heart, Bone, Testes, Colon, Skeletal Muscle
Sources

Publications for Compartment Syndrome

About this section

Articles related to Compartment Syndrome:

(show top 50) (show all 3048)
# Title Authors Year
1
Compartment syndrome of the forearm with life-threatening bleeding after fasciotomy as the presenting sign of postpartum acquired hemophilia A: a case report. ( 30864964 )
2019
2
Abdominal Compartment Syndrome After Liver Transplant in Drug-Induced Acute Liver Failure: A Case Report. ( 31101216 )
2019
3
Subcutaneous bleeding from arteriovenous fistula cannulation causes skin complication mimicking compartment syndrome. ( 30461336 )
2019
4
Successful treatment of abdominal compartment syndrome with chemotherapy in a patient with a newly diagnosed Burkitt lymphoma. ( 30710879 )
2019
5
Diagnostic Modalities for Acute Compartment Syndrome of the Extremities: A Systematic Review. ( 31042278 )
2019
6
Abdominal Compartment Syndrome in Critically Ill Patients. ( 31049088 )
2019
7
Compartment syndrome of the muscles of mastication in a working dog following a traumatic training incident. ( 31066176 )
2019
8
Management of peripartum intra-abdominal hypertension and abdominal compartment syndrome. ( 31070780 )
2019
9
Spontaneous Compartment Syndrome of the Lower Extremity in a Patient on Warfarin. ( 31082832 )
2019
10
Acute Bilateral Compartment Syndrome of the Forearms. ( 31085089 )
2019
11
Deep posterior chronic exertional compartment syndrome as a cause of leg pain. ( 31098648 )
2019
12
Risk factors for complications following decompression of non-traumatic compartment syndrome. ( 31110399 )
2019
13
Fasciotomy for chronic exertional compartment syndrome of the leg: clinical outcome in a large retrospective cohort. ( 30145669 )
2019
14
Botulinum Toxin as a Novel Treatment for Chronic Exertional Compartment Syndrome in the U.S. Military. ( 30215765 )
2019
15
Chronic exertional compartment syndrome of the forearm. ( 30273097 )
2019
16
Lessons from Trauma Care: Abdominal Compartment Syndrome and Damage Control Laparotomy in the Patient with Gastrointestinal Disease. ( 30276590 )
2019
17
Use of Oxygen Tissue Monitoring in Patients With Compartment Syndrome: Two Clinical Cases and Literature Review. ( 30371908 )
2019
18
Bony Orbital Decompression Following Lateral Canthotomy and Cantholysis for Traumatic Orbital Compartment Syndrome. ( 30444775 )
2019
19
Abdominal compartment syndrome. ( 30454823 )
2019
20
Superficial Peroneal Nerve Injury Risk During a Semiblind Fasciotomy for Anterior Chronic Exertional Compartment Syndrome of the Leg: An Anatomical and Clinical Study. ( 30466306 )
2019
21
Acute hand pain resulting in spontaneous thenar compartment syndrome. ( 30527915 )
2019
22
Interventional Management of Subcapsular Hepatic Hematoma with Hepatic Compartment Syndrome After Laparoscopic Adrenalectomy. ( 30603970 )
2019
23
Low compartment pressure and myoglobin levels in tibial fractures with suspected acute compartment syndrome. ( 30611244 )
2019
24
Abdominal Compartment Syndrome in Children: Clinical and Imaging Features. ( 30645165 )
2019
25
Suspected Compartment Syndrome, Consumptive Thrombocytopenia, and Anemia Secondary to a Ruptured Arterial Aneurysm or Pseudoaneurysm Following Multiple Stifle Surgeries. ( 30653363 )
2019
26
Ocular Compartment Syndrome and Lateral Canthotomy Procedure. ( 30679067 )
2019
27
Evaluation and Management of Acute Compartment Syndrome in the Emergency Department. ( 30685220 )
2019
28
Fasciotomy in compartment syndrome from snakebite. ( 30685944 )
2019
29
Pediatric acute compartment syndrome: a systematic review and meta-analysis. ( 30688754 )
2019
30
Chronic exertional compartment syndrome and functional popliteal artery entrapment syndrome: differential diagnosis or related conditions? A case report. ( 30689303 )
2019
31
Tension pneumoperitoneum: Case report of a rare form of acute abdominal compartment syndrome. ( 30716704 )
2019
32
Abdominal compartment syndrome and intra-abdominal hypertension in critically ill patients: diagnostic value of computed tomography. ( 30737569 )
2019
33
Abdominal Compartment Syndrome. ( 30739646 )
2019
34
Feasibility of ultrasound measurement in a human model of acute compartment syndrome. ( 30740139 )
2019
35
Differences between primary and secondary definitive osteosynthesis for fractures of the lower leg with concomitant acute compartment syndrome. ( 30747274 )
2019
36
Acute Compartment Syndrome of the Forearm Secondary to Hematoma after Playing Golf. ( 30760147 )
2019
37
Aetiology of trauma-related acute compartment syndrome of the leg: A systematic review. ( 30772051 )
2019
38
Tetraplegia associated with post-operative syringomyelia in spinal tuberculosis: a result of an epidural compartment syndrome? ( 30774988 )
2019
39
Comparison of pressure-regulated volume control ventilation and pressure control ventilation in patients with abdominal compartment syndrome. ( 30783471 )
2019
40
Well leg compartment syndrome in trauma surgery - femoral shaft fracture treated by femoral intramedullary nailing in the hemilithotomy position: case series and review of the literature. ( 30799923 )
2019
41
Acute Traumatic Compartment Syndrome of the Forearm: Literature Review and Unfavorable Outcomes Risk Analysis of Fasciotomy Treatment. ( 30801492 )
2019
42
Surgical management of acute compartment syndrome and sequential complications. ( 30832634 )
2019
43
Severe Influenza A(H1N1) Virus Infection Complicated by Myositis, Refractory Rhabdomyolysis, and Compartment Syndrome. ( 30838046 )
2019
44
Atraumatic Gluteal Compartment Syndrome Presenting in a Young Female with Unilateral Lower Extremity Symptoms. ( 30838141 )
2019
45
Acute compartment syndrome: An orthopedic emergency. ( 30865061 )
2019
46
Compartment syndrome as a late presentation of brachial artery pseudoaneurysm following shaft of humerus fracture. ( 30872341 )
2019
47
Acute compartment syndrome: An orthopedic emergency. ( 30889107 )
2019
48
Acute Compartment Syndrome of the Hand from a Parrot Bite. ( 30891385 )
2019
49
Paraspinal Compartment Syndrome-an Insidious Cause of Acute Back Pain. ( 30905339 )
2019
50
Return to sports after chronic anterior exertional compartment syndrome of the leg: Conservative treatment versus surgery. ( 30909799 )
2019
Sources

Variations for Compartment Syndrome

About this section
Sources

Expression for Compartment Syndrome

About this section
Search GEO for disease gene expression data for Compartment Syndrome.
Sources

Pathways for Compartment Syndrome

About this section

Pathways related to Compartment Syndrome according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Formation of Fibrin Clot (Clotting Cascade) 67
Show member pathways
 11.63 F2 F7 F8
2
Complement and coagulation cascades 1 38
11.47 F2 F7 F8
3
Selenium Micronutrient Network 1
Show member pathways
 11.26 ALB F2 F7 TNF
4
Warfarin Pathway, Pharmacodynamics 62
10.13 F2 F7
Sources

GO Terms for Compartment Syndrome

About this section

Cellular components related to Compartment Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endoplasmic reticulum lumen GO:0005788 8.92 ALB F2 F7 F8

Biological processes related to Compartment Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 blood coagulation GO:0007596 9.5 F2 F7 F8
2 acute-phase response GO:0006953 9.37 F2 F8
3 blood coagulation, intrinsic pathway GO:0007597 9.26 F2 F8
4 positive regulation of blood coagulation GO:0030194 9.16 F2 F7
5 hemostasis GO:0007599 9.13 F2 F7 F8
6 ER to Golgi vesicle-mediated transport GO:0006888 8.92 ERGIC1 F2 F7 F8

Molecular functions related to Compartment Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 oxygen binding GO:0019825 8.62 ALB MB
Sources

Sources for Compartment Syndrome

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....